Grufity logo
Grufity logo
GNPX

GNPX - Genprex Inc Stock Price, Fair Value and News

$5.90-0.16 (-2.64%)
Market Closed as of 31 Jul 2026, 04:00 pm ET

Price Targets

GNPX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

GNPX Price Action

Last 7 days

-24.5%

Last 30 days

1013.2%

Last 90 days

541.3%

Trailing 12 Months

-48.9%

GNPX RSI Chart

GNPX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

GNPX Valuation

Market Cap

2.8M

Price/Earnings (Trailing)

-0.17

Price/Free Cashflow

-0.2

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

GNPX Fundamentals

GNPX Earnings

Earnings (TTM)

-16.7M

Earnings Growth (Yr)

-12.54%

Earnings Growth (Qtr)

-17.72%

GNPX Profitability

Return on Equity

-98.79%

Return on Assets

-82.37%

Free Cashflow Yield

-503.27%

GNPX Investor Care

Shares Dilution (1Y)

3367.25%

Revenue & Growth

How Genprex Inc generates revenue and covers its expenses, based on the latest reported earnings.

About Genprex Inc

GNPX
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) that is in Phase 1/2 and 2 clinical trials to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002 for the treatment of type 1 diabetes, and GPX-003 for the treatment of type 2 diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
 CEO
 WEBSITEgenprex.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES30

Genprex Inc Frequently Asked Questions

GNPX is the stock ticker symbol of Genprex Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Jul 31 2026, market cap of Genprex Inc is 2.84 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.